Camena Bioscience is a synthetic biology company that develops tools to engineer new synthetic biology applications.
Camena Bioscience has raised $10.0M in total funding. The most recent round was Series A. The last funding was announced in July 2023.
Camena Bioscience's investors include Mercia Asset Management.
Camena Bioscience is headquartered in Cambridge, United Kingdom.
Camena Bioscience is a synthetic biology company that develops tools to engineer new synthetic biology applications.
Camena Bioscience is at the Series A stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Camena Bioscience — Funding & Investors." VCBacked, July 3, 2023, https://www.vcbacked.co/company/camena-bioscience. Accessed September 14, 2026.
VCBacked. (2023). Camena Bioscience — Funding & Investors. Retrieved September 14, 2026, from https://www.vcbacked.co/company/camena-bioscience
{{cite web |title=Camena Bioscience — Funding & Investors |url=https://www.vcbacked.co/company/camena-bioscience |website=VCBacked |access-date=September 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated